Castle Biosciences to Participate in Upcoming Investor Conferences

FRIENDSWOOD, Texas--(BUSINESS WIRE)-- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at Baird’s 2024 Global Healthcare Conference on Wednesday, Sept. 11, 2024, at 9:05 a.m. Eastern time.

A live audio webcast of the Company’s presentation will be available by visiting Castle Biosciences’ website at ir.castlebiosciences.com/events-presentations/. A replay of the webcast will be available following the conclusion of the live broadcast.

Castle will also be available for one-on-one investor meetings during the 8th Annual Lake Street Best Ideas Growth (BIG8) Conference on Sept. 12, 2024. Meetings may be requested exclusively through Lake Street Capital Markets.

About Castle Biosciences

Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.

Castle’s current portfolio consists of tests for skin cancers, Barrett’s esophagus, mental health conditions and uveal melanoma. Additionally, the Company has active research and development programs for tests in other diseases with high clinical need, including its test in development to help guide systemic therapy selection for patients with moderate-to-severe atopic dermatitis, psoriasis and related conditions. To learn more, please visit www.CastleBiosciences.com and connect with us on LinkedIn, Facebook, X and Instagram.

DecisionDx-Melanoma, DecisionDx-CMSeq, DecisionDx-SCC, MyPath Melanoma, DiffDx-Melanoma, TissueCypher, IDgenetix, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240828537095/en/

Investor Contact:

Camilla Zuckero

czuckero@castlebiosciences.com

Media Contact:

Allison Marshall

amarshall@castlebiosciences.com

Source: Castle Biosciences Inc.

FAQ

When is Castle Biosciences (CSTL) presenting at Baird's 2024 Global Healthcare Conference?

Castle Biosciences (CSTL) is scheduled to present at Baird's 2024 Global Healthcare Conference on Wednesday, September 11, 2024, at 9:05 a.m. Eastern time.

How can investors access Castle Biosciences' (CSTL) presentation at Baird's conference?

Investors can access a live audio webcast of Castle Biosciences' (CSTL) presentation by visiting the company's website at ir.castlebiosciences.com/events-presentations/. A replay will be available after the live broadcast.

Is Castle Biosciences (CSTL) participating in the 8th Annual Lake Street Best Ideas Growth Conference?

Yes, Castle Biosciences (CSTL) will be available for one-on-one investor meetings during the 8th Annual Lake Street Best Ideas Growth (BIG8) Conference on September 12, 2024.

How can investors request meetings with Castle Biosciences (CSTL) at the Lake Street conference?

Investors can request one-on-one meetings with Castle Biosciences (CSTL) exclusively through Lake Street Capital Markets for the 8th Annual Lake Street Best Ideas Growth Conference.